» Articles » PMID: 20211135

MiR-328 Functions As an RNA Decoy to Modulate HnRNP E2 Regulation of MRNA Translation in Leukemic Blasts

Abstract

MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins.

Citing Articles

Recent insights and perspectives into the role of the miRNA‑29 family in innate immunity (Review).

Yao X, Wu J, Yuan S, Yuan F Int J Mol Med. 2025; 55(3).

PMID: 39886977 PMC: 11781520. DOI: 10.3892/ijmm.2025.5494.


MicroRNA Gets a Mighty Award.

Li Y, Chen S, Rao H, Cui S, Chen G Adv Sci (Weinh). 2025; 12(7):e2414625.

PMID: 39836690 PMC: 11831481. DOI: 10.1002/advs.202414625.


miR-276 and miR-182013-5p modulate insect metamorphosis and reproduction via dually regulating juvenile hormone acid methyltransferase.

Song J, Li W, Gao L, Yan Q, Zhang X, Liu M Commun Biol. 2024; 7(1):1604.

PMID: 39623057 PMC: 11612435. DOI: 10.1038/s42003-024-07285-0.


Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer.

Wang Y, Lazaridou M, Kordass T, Massa C, Vaxevanis C, Eichmuller S Clin Transl Med. 2024; 14(10):e70010.

PMID: 39439221 PMC: 11496566. DOI: 10.1002/ctm2.70010.


MicroRNAs in diabetic macroangiopathy.

Rao G, Peng B, Zhang G, Fu X, Tian J, Tian Y Cardiovasc Diabetol. 2024; 23(1):344.

PMID: 39285459 PMC: 11406791. DOI: 10.1186/s12933-024-02405-w.


References
1.
Chang J, Santhanam R, Trotta R, Neviani P, Eiring A, Briercheck E . High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood. 2007; 110(3):994-1003. PMC: 1924762. DOI: 10.1182/blood-2007-03-078303. View

2.
Guil S, Caceres J . The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol. 2007; 14(7):591-6. DOI: 10.1038/nsmb1250. View

3.
Eiring A, Neviani P, Santhanam R, Oaks J, Chang J, Notari M . Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis. Blood. 2007; 111(2):816-28. PMC: 2200861. DOI: 10.1182/blood-2007-05-090472. View

4.
Fujimura K, Kano F, Murata M . Identification of PCBP2, a facilitator of IRES-mediated translation, as a novel constituent of stress granules and processing bodies. RNA. 2008; 14(3):425-31. PMC: 2248264. DOI: 10.1261/rna.780708. View

5.
Johnnidis J, Harris M, Wheeler R, Stehling-Sun S, Lam M, Kirak O . Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008; 451(7182):1125-9. DOI: 10.1038/nature06607. View